AKYA

Akoya Biosciences, Inc.

Insider trading activity for Akoya Biosciences, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 65 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 8, 2025	Mendel Scott	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Mendel Scott	Director	JOTHER◆	44,959	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Mendel Scott	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Mendel Scott	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Mendel Scott	Director	JOTHER◆	35,562	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Mendel Scott	Director	JOTHER	28,500	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER◆	70,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER◆	45,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER◆	45,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER◆	62,566	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER	130,625	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER	151,930	—	—	-53.8%	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	FTAX	42,148	—	—	-13.0%	Open the original filing on SEC.gov
Jul 8, 2025	Ramachandran Niro Ph.D	Chief Business Officer	JOTHER	62,566	—	—	+23.9%	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	175,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	160,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	160,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	241,592	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	331,090	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER◆	393,338	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER	947,688	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	FTAX	196,866	—	—	-17.2%	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER	331,090	—	—	+40.7%	Open the original filing on SEC.gov
Jul 8, 2025	McKelligon Brian	President and CEO	JOTHER	393,338	—	—	+93.6%	Open the original filing on SEC.gov
Jul 8, 2025	Kamocsay Jennifer	Chief Legal Officer	JOTHER◆	70,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Kamocsay Jennifer	Chief Legal Officer	JOTHER◆	75,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Kamocsay Jennifer	Chief Legal Officer	JOTHER	162,500	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Kamocsay Jennifer	Chief Legal Officer	JOTHER	16,772	—	—	-9.4%	Open the original filing on SEC.gov
Jul 8, 2025	Ek John Frederick	CFO	JOTHER◆	70,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ek John Frederick	CFO	JOTHER◆	160,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Ek John Frederick	CFO	JOTHER	20,000	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Ek John Frederick	CFO	JOTHER	193,750	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Ek John Frederick	CFO	JOTHER	54,452	—	—	-21.9%	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER◆	15,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER◆	25,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER◆	150,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER	196,250	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Bamford Pascal	Chief Clinical Officer	JOTHER	9,488	—	—	-4.6%	Open the original filing on SEC.gov
Jul 8, 2025	Winkler Matthew	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Winkler Matthew	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Winkler Matthew	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Winkler Matthew	Director	JOTHER◆	16,860	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Winkler Matthew	Director	JOTHER	984,513	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Shepler Robert G	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Shepler Robert G	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Shepler Robert G	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Shepler Robert G	Director	JOTHER◆	16,860	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Schnettler Thomas P	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Schnettler Thomas P	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Schnettler Thomas P	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Schnettler Thomas P	Director	JOTHER◆	16,860	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER◆	16,860	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER	15.9M	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER	1.7M	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Raffin Thomas A.	Director	JOTHER	234,592	—	—	-100.0%	Open the original filing on SEC.gov
Jul 8, 2025	Lai Goldman Myla	Director	JOTHER◆	50,000	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Lai Goldman Myla	Director	JOTHER◆	56,322	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Lai Goldman Myla	Director	JOTHER◆	30,549	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Lai Goldman Myla	Director	JOTHER◆	38,993	—	—	—	Open the original filing on SEC.gov
Jul 8, 2025	Lai Goldman Myla	Director	JOTHER	20,000	—	—	-100.0%	Open the original filing on SEC.gov
Jun 1, 2025	Bamford Pascal	Chief Clinical Officer	FTAX	670	$1.25	$838	-0.3%	Open the original filing on SEC.gov

JOTHER◆—

Mendel Scott · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Mendel Scott · DirectorJul 8, 2025

44,959 sh

JOTHER◆—

Mendel Scott · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Mendel Scott · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Mendel Scott · DirectorJul 8, 2025

35,562 sh

JOTHER—

Mendel Scott · DirectorJul 8, 2025

28,500 sh · -100.0% own

JOTHER◆—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

70,000 sh

JOTHER◆—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

45,000 sh

JOTHER◆—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

45,000 sh

JOTHER◆—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

62,566 sh

JOTHER—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

130,625 sh · -100.0% own

JOTHER—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

151,930 sh · -53.8% own

FTAX—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

42,148 sh · -13.0% own

JOTHER—

Ramachandran Niro Ph.D · Chief Business…Jul 8, 2025

62,566 sh · +23.9% own

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

175,000 sh

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

160,000 sh

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

160,000 sh

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

241,592 sh

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

331,090 sh

JOTHER◆—

McKelligon Brian · President and CEOJul 8, 2025

393,338 sh

JOTHER—

McKelligon Brian · President and CEOJul 8, 2025

947,688 sh · -100.0% own

FTAX—

McKelligon Brian · President and CEOJul 8, 2025

196,866 sh · -17.2% own

JOTHER—

McKelligon Brian · President and CEOJul 8, 2025

331,090 sh · +40.7% own

JOTHER—

McKelligon Brian · President and CEOJul 8, 2025

393,338 sh · +93.6% own

JOTHER◆—

Kamocsay Jennifer · Chief Legal…Jul 8, 2025

70,000 sh

JOTHER◆—

Kamocsay Jennifer · Chief Legal…Jul 8, 2025

75,000 sh

JOTHER—

Kamocsay Jennifer · Chief Legal…Jul 8, 2025

162,500 sh · -100.0% own

JOTHER—

Kamocsay Jennifer · Chief Legal…Jul 8, 2025

16,772 sh · -9.4% own

JOTHER◆—

Ek John Frederick · CFOJul 8, 2025

70,000 sh

JOTHER◆—

Ek John Frederick · CFOJul 8, 2025

160,000 sh

JOTHER—

Ek John Frederick · CFOJul 8, 2025

20,000 sh · -100.0% own

JOTHER—

Ek John Frederick · CFOJul 8, 2025

193,750 sh · -100.0% own

JOTHER—

Ek John Frederick · CFOJul 8, 2025

54,452 sh · -21.9% own

JOTHER◆—

Bamford Pascal · Chief Clinical…Jul 8, 2025

50,000 sh

JOTHER◆—

Bamford Pascal · Chief Clinical…Jul 8, 2025

15,000 sh

JOTHER◆—

Bamford Pascal · Chief Clinical…Jul 8, 2025

25,000 sh

JOTHER◆—

Bamford Pascal · Chief Clinical…Jul 8, 2025

150,000 sh

JOTHER—

Bamford Pascal · Chief Clinical…Jul 8, 2025

196,250 sh · -100.0% own

JOTHER—

Bamford Pascal · Chief Clinical…Jul 8, 2025

9,488 sh · -4.6% own

JOTHER◆—

Winkler Matthew · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Winkler Matthew · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Winkler Matthew · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Winkler Matthew · DirectorJul 8, 2025

16,860 sh

JOTHER—

Winkler Matthew · DirectorJul 8, 2025

984,513 sh · -100.0% own

JOTHER◆—

Shepler Robert G · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Shepler Robert G · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Shepler Robert G · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Shepler Robert G · DirectorJul 8, 2025

16,860 sh

JOTHER◆—

Schnettler Thomas P · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Schnettler Thomas P · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Schnettler Thomas P · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Schnettler Thomas P · DirectorJul 8, 2025

16,860 sh

JOTHER◆—

Raffin Thomas A. · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Raffin Thomas A. · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Raffin Thomas A. · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Raffin Thomas A. · DirectorJul 8, 2025

16,860 sh

JOTHER—

Raffin Thomas A. · DirectorJul 8, 2025

15.9M sh · -100.0% own

JOTHER—

Raffin Thomas A. · DirectorJul 8, 2025

1.7M sh · -100.0% own

JOTHER—

Raffin Thomas A. · DirectorJul 8, 2025

234,592 sh · -100.0% own

JOTHER◆—

Lai Goldman Myla · DirectorJul 8, 2025

50,000 sh

JOTHER◆—

Lai Goldman Myla · DirectorJul 8, 2025

56,322 sh

JOTHER◆—

Lai Goldman Myla · DirectorJul 8, 2025

30,549 sh

JOTHER◆—

Lai Goldman Myla · DirectorJul 8, 2025

38,993 sh

JOTHER—

Lai Goldman Myla · DirectorJul 8, 2025

20,000 sh · -100.0% own

FTAX$838

Bamford Pascal · Chief Clinical…Jun 1, 2025

670 sh @ $1.25 · -0.3% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 12 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More healthcare services companies

Other issuers in the same industry with insider filings on record.

Whole sector →